GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) is a publicly traded Healthcare sector company. As of September 13, 2026, GSK trades at $48.13 with a market cap of $96.43B and a P/E ratio of 0.00. GSK moved +0.02% today. Year to date, GSK is -1.86%; over the trailing twelve months it is +16.03%. Its 52-week range spans $32.38 to $61.70. Analyst consensus is neutral with an average price target of $70.00. Rallies surfaces GSK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for GSK combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $48.13 |
| Market Cap | $96.43B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.45% |
| 52-Week High | $61.70 |
| 52-Week Low | $32.38 |
| Volume | 2.12M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover GSK: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $70.00.